Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in Ireland
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Dublin 7
- Age
- 18 years to 75 years
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - Phase 3Taking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Dublin 7
- Age
- 18 years to 75 years
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00